Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Onboard a new entity or clinic

Reporting agreement form

Email completed form to vaxreporting​@phila.gov or fax to the contact above.

Clinic onboarding list

To onboard more than 2 clinics.


On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

V-Safe for Monkeypox Vaccine: Survey to Assess Promotion Willingness and Perceived Barriers

V-Safe for Monkeypox Vaccine: Survey to Assess Promotion Willingness and Perceived Barriers

V-Safe for Monkeypox Vaccine: Survey to Assess Promotion Willingness and Perceived Barriers

The Immunization Safety Office at CDC will soon be going live with a monkeypox module in CDC’s v-safe After Vaccination Health Checker. V-safe is a voluntary smartphone-based system that uses text messaging and web surveys to provide personalized and confidential health check-ins. Participants can tell CDC how they, or their child or dependent, feel after they receive a monkeypox vaccine.Based on the success of v-safe for COVID-19, the CDC has found that promoting and encouraging enrollment at the vaccine delivery site is the best way to make vaccine recipients aware of v-safe. Please fill out this short survey to assess willingness and perceived barriers to promotion of v-safe at your practice.